Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment

BACKGROUND & AIMS: Previously, we showed the inhibitor of differentiation or DNA binding 1 (ID1)/Myc signaling is highly expressed in oxaliplatin-resistant hepatocellular carcinoma (HCC). This study sought to investigate the role of ID1/Myc signaling on immune evasion in oxaliplatin-resistant HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Feng, Hu, Keshu, Liu, Wenfeng, Quan, Bing, Li, Miao, Lu, Shenxin, Chen, Rongxin, Ren, Zhenggang, Yin, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868681/
https://www.ncbi.nlm.nih.gov/pubmed/36513250
http://dx.doi.org/10.1016/j.jcmgh.2022.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868681/
https://www.ncbi.nlm.nih.gov/pubmed/36513250
http://dx.doi.org/10.1016/j.jcmgh.2022.12.002

Ejemplares similares